These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6762142)

  • 1. Estrogen action in human breast cancer (review).
    Edwards DP; McGuire WL
    Anticancer Res; 1982; 2(5):297-308. PubMed ID: 6762142
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
    Eckert RL; Katzenellenbogen BS
    Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic adenosine-3':5'-monophosphate binding proteins in human mammary tumor cytosol and their relation to estrogen and progesterone receptors. A preliminary study.
    De Bortoli M; Fumero S; Mondino A
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):226-32. PubMed ID: 6860498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oestrogen-induced proteins in breast cancer (author's transl)].
    Vignon F; Capony F; Garcia M; Veith F; Westley B; Rochefort H
    Ann Endocrinol (Paris); 1981; 42(4-5):327-32. PubMed ID: 7200344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen regulation of specific proteins as a mode of hormone action in human breast cancer.
    Adams DJ; Edwards DP; McGuire WL
    Biomembranes; 1983; 11():389-414. PubMed ID: 6338951
    [No Abstract]   [Full Text] [Related]  

  • 6. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
    Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
    Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroid hormone receptors in breast cancer (a review of the literature)].
    Korolev VI; Dziubko NIa; Tarutinov VI
    Vrach Delo; 1988 Nov; (11):86-91. PubMed ID: 2853492
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase.
    Zelinski DP; Zantek ND; Walker-Daniels J; Peters MA; Taparowsky EJ; Kinch MS
    J Cell Biochem; 2002; 85(4):714-20. PubMed ID: 11968011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of malignant breast tumors containing estrogen receptors].
    El'tsina NV
    Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
    [No Abstract]   [Full Text] [Related]  

  • 13. Recovery of cellular E-cadherin precedes replenishment of estrogen receptor and estrogen-dependent proliferation of breast cancer cells rescued from a death stimulus.
    Malaguti C; Rossini GP
    J Cell Physiol; 2002 Aug; 192(2):171-81. PubMed ID: 12115723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
    Smith RA; Lea RA; Weinstein SR; Griffiths LR
    Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
    Di GH; Lu JS; Song CG; Li HC; Shen ZZ; Shao ZM
    J Exp Clin Cancer Res; 2005 Dec; 24(4):601-7. PubMed ID: 16471323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
    Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormones, platinum, and cancer of the breast].
    Jeanteur P
    Bull Cancer; 2000 Jul; 87(7-8):521-2. PubMed ID: 10969202
    [No Abstract]   [Full Text] [Related]  

  • 20. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
    Pewnim T; Adams JB; Ho KP
    Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.